Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · USD
$27.0
-0.71 (-2.6%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first BCAX analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 1.8B | |
|---|---|---|
| Net income (ttm) | -157.3M | |
| EPS (ttm) | -$2.80 | |
| Shares out | 65.7M | |
| Volume | 481,656 | |
| Price target | $31.5 | +16.4% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Net income (ttm)
- -157.3M
- EPS (ttm)
- -$2.80
- Market cap
- 1.8B
Fair-value bridge
- Current price
- $27.0
Analyst consensus
Recommendation
Buy
Price target
$31.5
+16.4%
In the news
Latest news · BCAX
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 1.8B
- P/B
- 3.4x
Profitability
- ROE
- -32.3%
- ROA
- -21.1%
- ROIC
- -22.3%
Balance sheet
- Debt / equity
- 0.00
- Current ratio
- 13.85
- Quick ratio
- 13.72
Trading
- Volume
- 481,656
- Dividend yield
- 0.0%